Graciela Landeira

ORCID: 0000-0003-0015-1397
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Hepatitis C virus research
  • Liver Diseases and Immunity
  • Hepatitis B Virus Studies
  • Hepatitis Viruses Studies and Epidemiology
  • Appendicitis Diagnosis and Management
  • Salmonella and Campylobacter epidemiology
  • HIV/AIDS Research and Interventions
  • Gallbladder and Bile Duct Disorders
  • Pediatric Hepatobiliary Diseases and Treatments
  • Thyroid Cancer Diagnosis and Treatment
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Alcohol Consumption and Health Effects
  • Renal function and acid-base balance
  • Cardiovascular, Neuropeptides, and Oxidative Stress Research
  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • Thyroid Disorders and Treatments
  • Diabetes Treatment and Management
  • Systemic Lupus Erythematosus Research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Lipid metabolism and disorders
  • Gastroesophageal reflux and treatments
  • Drug-Induced Hepatotoxicity and Protection

Hospital Posadas
2000-2025

Nonalcoholic steatohepatitis may cause severe fibrosis, cirrhosis, and hepatocellular carcinoma, but supporting evidence is based on indirect data. Few publications have examined the results of repeat liver biopsies to evaluate progression fibrosis. The aims this study were assess rate fibrosis in untreated patients with nonalcoholic identify associated variables. Among 106 patients, a second biopsy was proposed those who had undergone their first at least 3 years before. None them been...

10.1002/hep.20410 article EN Hepatology 2004-01-01

Metabolic dysfunction-associated steatotic liver disease (MASLD) patients have a higher incidence of cardiovascular events (CVE) compared to controls. Aim The aim this study is analyze association between fibrosis with CVE, incident diabetes, and cirrhosis complications. Methods Historic cohort biopsy-proven MASLD patients, divided into two groups: F0–F2 vs F3–F4 fibrosis. Baseline data included metabolic traits function tests. Patients were contacted scheduled for laboratory analysis...

10.1097/meg.0000000000002943 article EN European Journal of Gastroenterology & Hepatology 2025-02-20

The objectives of this study were to investigate the prevalence infections with hepatotrophic viruses in an anti‐human immunodeficiency virus (HIV)‐positive population from Buenos Aires and compare it among main risk groups for HIV infection. Four hundred eighty‐four consecutive patients attending outpatients clinic studied: 359 men 125 women, median age 29 years (range 16–67 years); 35.5% had presented acquired immune deficiency syndrome (AIDS)‐defining conditions. Two thirty‐four...

10.1046/j.1365-2893.1999.t01-1-6120135.x article EN Journal of Viral Hepatitis 1999-01-01

Treatment with β-blockers fails to decrease portal pressure in nearly 40% of cirrhotic patients. Recent studies have suggested that treatment spironolactone reduces and flow the variceal systems. This trial was designed assess if nadolol plus is more effective than alone prevent first bleeding. One hundred patients medium large varices who had never bled were without ascites included a prospective, randomized, multicenter, double-blind, placebo-controlled trial. The randomized into 2 groups:...

10.1053/jhep.2003.50032 article EN Hepatology 2003-02-01

Nonalcoholic steatohepatitis may cause severe fibrosis, cirrhosis, and hepatocellular carcinoma, but supporting evidence is based on indirect data. Few publications have examined the results of repeat liver biopsies to evaluate progression fibrosis. The aims this study were assess rate fibrosis in untreated patients with nonalcoholic identify associated variables. Among 106 patients, a second biopsy was proposed those who had undergone their first at least 3 years before. None them been...

10.1002/hep.1840400411 article EN Hepatology 2004-10-01

Material and methods. With the aim of analyzing influence presence cirrhosis at baseline on outcome, we revised evolution a cohort patients with type 1 autoimmune hepatitis, prospectively followed single hospital. 139 (113 females, 26 males), median age 45.7 years, interquartile range 13-59 were followed-up for period 58 months (interquartile 27-106). Results. At baseline, 55 had they significantly older, lower prothrombin activity serum albumin than without cirrhosis. In contrast, higher...

10.1016/s1665-2681(19)31493-0 article EN cc-by-nc-nd Annals of Hepatology 2012-01-01

It has been described as bacterial infections (BIs) due to multidrug-resistant bacteria (MRB) in cirrhosis with acute decompensation (AD), a potentially poor prognosis. This study aimed determine the frequency of BIs MRB tertiary centre and its association mortality. is prospective cohort study. Cirrhotics AD were enrolled. At admission, polymorphonuclear leukocytes (PMN) count was performed ascites patients. Blood, urine fluids cultures collected patients encephalopathy, ascites, digestive...

10.1016/j.aohep.2023.101025 article EN cc-by-nc-nd Annals of Hepatology 2023-03-01
Coming Soon ...